Literature DB >> 3432224

The early detection of cancer in the primary-care setting: factors associated with the acceptance and completion of recommended procedures.

R C Burack1, J Liang.   

Abstract

Effective cancer control efforts in the primary-care setting require that patients accept and are able to complete recommended early detection procedures. We thus assessed the extent to which procedure nonacceptance or noncompletion limited accomplishment of detection procedures offered as components of routine health care. We also examined the relationship of provider and patient factors to successful procedure accomplishment. Of 221 patients offered procedures by their primary-care provider, 58 (27%) initially declined at least one recommendation, with acceptance rates ranging from 98% for breast exam to 59% for sigmoidoscopy. Furthermore, only 50% of patients offered stool occult blood testing or sigmoidoscopy, 61% offered mammography, and 69% offered Pap smear were able to complete the procedures. Pap smear and mammography were more likely to be initially accepted by those patients with more years of formal education and were less likely to be completed by those with private insurance coverage. Among a subgroup of 76 patients completing a telephone interview, personal health beliefs were not consistently associated with procedure acceptance or completion. These results suggest that both the initial nonacceptance of procedures and the subsequent barriers to their completion limit the efficacy of cancer screening efforts in the primary-care setting. Future research will be required to develop an explanatory model or to propose a targeted intervention.

Entities:  

Mesh:

Year:  1987        PMID: 3432224     DOI: 10.1016/0091-7435(87)90014-4

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  28 in total

1.  Implementation of cancer prevention guidelines in clinical practice.

Authors:  S J McPhee; J A Bird
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Primary care residents' characteristics and motives for providing differential medical treatment of cervical cancer screening.

Authors:  Elva M Arredondo; Kathryn I Pollak; Philip Costanzo; Maya McNeilly; Evan Myers
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

Review 3.  Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior.

Authors:  Marc T Kiviniemi; Alyssa Bennett; Marie Zaiter; James R Marshall
Journal:  Psychooncology       Date:  2010-10-27       Impact factor: 3.894

4.  Time spent in the United States and breast cancer screening behaviors among ethnically diverse immigrant women: evidence for acculturation?

Authors:  William Michael Brown; Nathan S Consedine; Carol Magai
Journal:  J Immigr Minor Health       Date:  2006-10

5.  Facilitating factors for colorectal cancer screening.

Authors:  Corey H Brouse; Randi L Wolf; Charles E Basch
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

6.  Health Promotion: Whose job is it?

Authors:  R Wilson
Journal:  Can Fam Physician       Date:  1992-02       Impact factor: 3.275

7.  Screening sigmoidoscopy. Factors associated with utilization.

Authors:  S F Lewis; N M Jensen
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

8.  Health Belief Model variables as predictors of screening mammography utilization.

Authors:  R B Hyman; S Baker; R Ephraim; A Moadel; J Philip
Journal:  J Behav Med       Date:  1994-08

9.  Detroit's avoidable mortality project: breast cancer control for inner-city women.

Authors:  R C Burack; P A Gimotty; W Stengle; D Eckert; L Warbasse; A Moncrease
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

10.  Factors associated with perceived risk of breast cancer among women attending a screening program.

Authors:  S W Vernon; V G Vogel; S Halabi; M L Bondy
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.